1. Pin CL, Rukstalis JM, Johnson C, Konieczny SF: The bHLH transcription factor Mist1 is required to maintain exocrine pancreas cell organization and acinar cell identity. The Journal of cell biology 2001, 155(4):519-530.
2. Fazio EN, Everest M, Colman R, Wang R, Pin CL: Altered Glut-2 accumulation and beta-cell function in mice lacking the exocrine-specific transcription factor, Mist1. The Journal of endocrinology 2005, 187(3):407-418.
3. Direnzo D, Hess DA, Damsz B, Hallett JE, Marshall B, Goswami C, Liu Y, Deering T, Macdonald RJ, Konieczny SF: Induced Mist1 expression promotes remodeling of mouse pancreatic acinar cells. Gastroenterology 2012, 143(2):469-480.
4. Shi G, DiRenzo D, Qu C, Barney D, Miley D, Konieczny SF: Maintenance of acinar cell organization is critical to preventing Kras-induced acinar-ductal metaplasia. Oncogene 2013, 32(15):1950-1958.
5. Shi G, Zhu L, Sun Y, Bettencourt R, Damsz B, Hruban RH, Konieczny SF: Loss of the acinar-restricted transcription factor Mist1 accelerates Kras-induced pancreatic intraepithelial neoplasia. Gastroenterology 2009, 136(4):1368-1378.
6. Li X, Chen H, Liu Z, Ye Z, Gou S, Wang C: Overexpression of MIST1 reverses the epithelial-mesenchymal transition and reduces the tumorigenicity of pancreatic cancer cells via the Snail/E-cadherin pathway. Cancer letters 2018, 431:96-104.
7. Raglow Z, Thomas SM: Tumor matrix protein collagen XIα1 in cancer. Cancer letters 2015, 357(2):448-453.
8. Yoshioka H, Greenwel P, Inoguchi K, Truter S, Inagaki Y, Ninomiya Y, Ramirez F: Structural and functional analysis of the promoter of the human alpha 1(XI) collagen gene. The Journal of biological chemistry 1995, 270(1):418-424.
9. Wu YH, Chang TH, Huang YF, Chen CC, Chou CY: COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilization. Oncotarget 2015, 6(27):23748-23763.
10. Cheon DJ, Tong Y, Sim MS, Dering J, Berel D, Cui X, Lester J, Beach JA, Tighiouart M, Walts AE et al: A collagen-remodeling gene signature regulated by TGF-β signaling is associated with metastasis and poor survival in serous ovarian cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2014, 20(3):711-723.
11. Wu YH, Chang TH, Huang YF, Huang HD, Chou CY: COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer. Oncogene 2014, 33(26):3432-3440.
12. Sok JC, Lee JA, Dasari S, Joyce S, Contrucci SC, Egloff AM, Trevelline BK, Joshi R, Kumari N, Grandis JR et al: Collagen type XI α1 facilitates head and neck squamous cell cancer growth and invasion. British journal of cancer 2013, 109(12):3049-3056.
13. Min J, Vega PN, Engevik AC, Williams JA, Yang Q, Patterson LM, Simmons AJ, Bliton RJ, Betts JW, Lau KS et al: Heterogeneity and dynamics of active Kras-induced dysplastic lineages from mouse corpus stomach. Nature communications 2019, 10(1):5549.
14. Hata M, Kinoshita H, Hayakawa Y, Konishi M, Tsuboi M, Oya Y, Kurokawa K, Hayata Y, Nakagawa H, Tateishi K et al: GPR30-Expressing Gastric Chief Cells Do Not Dedifferentiate But Are Eliminated via PDK-Dependent Cell Competition During Development of Metaplasia. Gastroenterology 2020, 158(6):1650-1666 e1615.
15. Nienhuser H, Kim W, Malagola E, Ruan T, Valenti G, Middelhoff M, Bass A, Der CJ, Hayakawa Y, Wang TC: Mist1+ gastric isthmus stem cells are regulated by Wnt5a and expand in response to injury and inflammation in mice. Gut 2021, 70(4):654-665.
16. Huh WJ, Esen E, Geahlen JH, Bredemeyer AJ, Lee AH, Shi G, Konieczny SF, Glimcher LH, Mills JC: XBP1 controls maturation of gastric zymogenic cells by induction of MIST1 and expansion of the rough endoplasmic reticulum. Gastroenterology 2010, 139(6):2038-2049.
17. Martinelli P, Carrillo-de Santa Pau E, Cox T, Sainz B, Jr., Dusetti N, Greenhalf W, Rinaldi L, Costello E, Ghaneh P, Malats N et al: GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer. Gut 2017, 66(9):1665-1676.
18. Wu YH, Huang YF, Chang TH, Chen CC, Wu PY, Huang SC, Chou CY: COL11A1 activates cancer-associated fibroblasts by modulating TGF-beta3 through the NF-kappaB/IGFBP2 axis in ovarian cancer cells. Oncogene 2021, 40(26):4503-4519.
19. Nallanthighal S, Heiserman JP, Cheon DJ: Collagen Type XI Alpha 1 (COL11A1): A Novel Biomarker and a Key Player in Cancer. Cancers 2021, 13(5).
20. Lemercier C, To RQ, Carrasco RA, Konieczny SF: The basic helix-loop-helix transcription factor Mist1 functions as a transcriptional repressor of myoD. The EMBO journal 1998, 17(5):1412-1422.
21. Tran T, Jia D, Sun Y, Konieczny SF: The bHLH domain of Mistl is sufficient to activate gene transcription. Gene expression 2007, 13(4-5):241-253.
22. Kolonko M, Greb-Markiewicz B: bHLH-PAS Proteins: Their Structure and Intrinsic Disorder. International journal of molecular sciences 2019, 20(15).
23. Jia D, Liu Z, Deng N, Tan TZ, Huang RY, Taylor-Harding B, Cheon DJ, Lawrenson K, Wiedemeyer WR, Walts AE et al: A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets. Cancer letters 2016, 382(2):203-214.
24. Zhang B, Zhang C, Yang X, Chen Y, Zhang H, Liu J, Wu Q: Cytoplasmic collagen XIalphaI as a prognostic biomarker in esophageal squamous cell carcinoma. Cancer biology & therapy 2018, 19(5):364-372.
25. Tu H, Li J, Lin L, Wang L: COL11A1 Was Involved in Cell Proliferation, Apoptosis and Migration in Non-Small Cell Lung Cancer Cells. Journal of investigative surgery : the official journal of the Academy of Surgical Research 2021, 34(6):664-669.
26. Shen L, Yang M, Lin Q, Zhang Z, Zhu B, Miao C: COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance. Oncology reports 2016, 36(2):877-885.